BRIEF published on 06/10/2026 at 18:05, 1 month 27 days ago Oxurion Receives Notification on Shareholding Change Shares Transparency Notification Belgium Atlas Special Opportunities Oxurion
PRESS RELEASE published on 06/10/2026 at 18:00, 1 month 27 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding crossing the threshold. Oxurion is a technology-enabled clinical research company Clinical Research Transparency Notification Shareholding Oxurion NV Atlas Special Opportunities II, LLC
BRIEF published on 06/08/2026 at 21:05, 1 month 29 days ago Oxurion announces its software strategy with Exagis Growth Strategy Clinical Research Software Oxurion Exaggerate
BRIEF published on 06/08/2026 at 21:05, 1 month 29 days ago Oxurion Unveils Software-Driven Growth Strategy with Exagis Oxurion Clinical Data Management Exagis Software Strategy EClinical Platform
PRESS RELEASE published on 06/08/2026 at 21:00, 1 month 29 days ago Oxurion launches a software-driven growth strategy with Exagis Oxurion NV announces the software-driven growth strategy launch centered on Exagis, its proprietary clinical research platform. The platform evolves into a broad CDMS commercially serving clinical development market Oxurion NV Exagis Clinical Research Platform Software-driven Growth Strategy CDMS
BRIEF published on 06/03/2026 at 18:05, 2 months 4 days ago Oxurion Announces the Results of its Annual General Meeting Pharmaceutical Investments General Assembly Results Oxurion
BRIEF published on 06/03/2026 at 18:05, 2 months 4 days ago Oxurion Approves Agenda at Annual Shareholders' Meeting Forward-looking Statements Shareholders' Meeting Oxurion NV Leuven Agenda Approval
PRESS RELEASE published on 06/03/2026 at 18:00, 2 months 4 days ago Oxurion Announces Results on the Annual Shareholders' Meeting of 1 June 2026 Oxurion NV (Euronext Brussels: OXUR) successfully held its annual shareholders' meeting in Leuven, with all agenda items approved. Find more about the biopharmaceutical company at oxurion.com Biopharmaceutical Euronext Brussels Annual Shareholders' Meeting Oxurion NV Leuven
BRIEF published on 06/02/2026 at 18:05, 2 months 5 days ago Oxurion expands its clinical research offering targeting GLP-1 and peptides Clinical Research GLP-1 Oxurion Peptides Biometrics
BRIEF published on 06/02/2026 at 18:05, 2 months 5 days ago Oxurion Expands Services to Meet Growing Demand in GLP-1 Clinical Research Clinical Research Oxurion Peptide Therapeutics GLP-1 Market Biometrics Services
Published on 08/07/2026 at 23:15, 17 hours 17 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 17 hours 32 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 18 hours 2 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 18 hours 17 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 6 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 17 hours 11 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 21 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 21 hours 17 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 22 hours 22 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 21 hours 38 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 21 hours 51 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 17:49, 22 hours 42 minutes ago Crédit Agricole CIB announced the publication of the Amendment of its 2025 Universal Registration Document
Published on 08/07/2026 at 08:30, 1 day 8 hours ago Disclosure of shares outstanding and voting rights - 07.08.2026
